Doctor profile · Federal record

Dr. Lori Lavelle, DO

Rheumatology Physician (CMS: Rheumatology) · Duncansville, PA

  • NPI 1639162241
  • Accepts Medicare
  • MIPS 86.8 / 100 · 2023
  • 26 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
175 Meadowbrook Ln
Duncansville, PA 166358445
(814) 693-0300
fax (814) 693-0400

Credentials & registration

NPPES · NUCC
NPI registered
August 2005 — 21 yrs on file
Profile last updated
May 9, 2011
Year of graduation
2000 — 26 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Pennsylvania #0S012052
Medicaid
PA #1007706880003

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1639162241. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
64,243
Distinct HCPCS
10
Medicare allowed
$501,411
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 57,000 22 $5
J0897 Injection, denosumab, 1 mg 1,560 18 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 567 377 $122
36415 Insertion of needle into vein for collection of blood sample 494 328 $8
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 492 333 $8
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated 486 324 $4
86140 Measurement c-reactive protein for detection of infection or inflammation 471 319 $5
86235 Measurement of antibody for assessment of autoimmune disorder, any method 377 67 $18
80053 Blood test, comprehensive group of blood chemicals 327 241 $10
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 275 21 $69

In context: peer comparison

Among 2 peers in this city , average services per provider: 2,061. This provider delivers 31× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,723
Transactions
207
Manufacturers
12
Payer (manufacturer) Industry Txns Amount
ABBVIE INC. 109 $1,171.29
Amgen Inc. 21 $350.28
Novartis Pharmaceuticals Corporation 14 $253.72
GlaxoSmithKline, LLC. 22 $231.01
Janssen Biotech, Inc. 9 $182.12
AstraZeneca Pharmaceuticals LP 8 $147.82
PFIZER INC. 12 $141.31
UCB, Inc. 5 $106.60
E.R. Squibb & Sons, L.L.C. 3 $53.45
Aurinia Pharma U.S., Inc. 2 $38.36
GENZYME CORPORATION 1 $30.51
Novo Nordisk Inc 1 $16.67

By nature of payment

Food and Beverage
$2,723

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
3,713
Patients
1,427
Total drug cost
$678,426
Drug Type Claims Patients Total cost
Hydroxychloroquine Sulfate Generic 676 257 $42,480
Methotrexate (Methotrexate Sodium) Brand 378 135 $16,778
Methylprednisolone Generic 358 211 $6,026
Leflunomide Generic 349 130 $35,437
Gabapentin Generic 277 104 $6,145
Tramadol Hcl Generic 265 59 $2,871
Sulfasalazine Generic 256 104 $5,099
Meloxicam Generic 241 107 $1,787
Prednisone Generic 233 126 $2,027
Duloxetine Hcl Generic 137 47 $5,034

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Lori Lavelle's medical specialty?
Dr. Lori Lavelle practices Rheumatology Physician in Duncansville, PA.
Where does Dr. Lori Lavelle practice?
Dr. Lori Lavelle practices at 175 Meadowbrook Ln, Duncansville, PA 166358445. Office phone: 8146930300.
What is Dr. Lori Lavelle's NPI?
Dr. Lori Lavelle's National Provider Identifier (NPI) is 1639162241, issued by NPPES.
Does Dr. Lori Lavelle accept Medicare assignment?
Yes. Dr. Lori Lavelle accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Lori Lavelle commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.